New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 25, 2020 - The FDA announced the approval of Zogenix’s Fintepla (fenfluramine), for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.
Download PDF
Return to publications
